X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com//news-release/2024/03/14/2846238/0/en/Keros-Therapeutics-Announces-U-S-FDA-Fast-Track-Designation-for-KER-050-in-Lower-Risk-Myelodysplastic-Syndromes.html
https://www.globenewswire.com//news-release/2024/03/05/2840359/0/en/Keros-Therapeutics-to-Present-at-Leerink-Partners-2024-Global-Biopharma-Conference.html
https://www.globenewswire.com//news-release/2024/02/28/2837390/0/en/Keros-Therapeutics-Reports-Recent-Business-Highlights-and-Fourth-Quarter-and-Full-Year-2023-Financial-Results.html
https://ir.kerostx.com/news-releases/news-release-details/keros-therapeutics-present-pulmonary-vascular-research-institute
https://www.globenewswire.com//news-release/2024/01/09/2806216/0/en/Keros-Therapeutics-Announces-Closing-of-Upsized-Public-Offering-of-Common-Stock.html
https://www.globenewswire.com//news-release/2024/01/04/2803690/0/en/Keros-Therapeutics-Announces-Pricing-of-Upsized-Public-Offering-of-Common-Stock.html
https://www.globenewswire.com//news-release/2024/01/03/2803625/0/en/Keros-Therapeutics-Announces-Proposed-Public-Offering-of-Common-Stock.html
https://www.globenewswire.com//news-release/2024/01/03/2803233/0/en/Keros-Therapeutics-to-Develop-KER-065-for-the-Treatment-of-Obesity.html
https://www.globenewswire.com//news-release/2023/12/11/2793674/0/en/Keros-Therapeutics-Presents-Clinical-Data-from-its-KER-050-Program-at-the-65th-American-Society-of-Hematology-Annual-Meeting-and-Exposition.html
https://www.globenewswire.com//news-release/2023/11/07/2775032/0/en/Keros-Therapeutics-to-Present-at-Upcoming-Healthcare-Conferences.html
Market Place
Share 
